Barclays
APLM icon

Barclays’s Apollomics APLM Stock Holding History

Barclays’s Portfolio APLM Stock Details APLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9
Closed -$3.39K – 5216
2023
Q3 		$3.39K Buy
+9
New +$4.4K ﹤0.01% 4421

Other funds holding APLM

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
B
Bensler Bellevue, Washington $1.13B AUM 38.91% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
ZIG
Zullo Investment Group Scranton, Pennsylvania $264M AUM 26.77% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Barclays's APLM Position: Q4 2023 in Review

Barclays sold out of Apollomics (APLM) in Q4 2023, closing a stake of 9 shares — an estimated $3.39K sold.

Barclays first reported a position in APLM in Q3 2023 and held it in 1 quarter. The position peaked at $3.39K in Q3 2023. 12 funds tracked by Wall St. Rank hold APLM as of Q4 2023.

  • Barclays reported no remaining Apollomics position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 9 Apollomics shares in Q4 2023, an estimated $3.39K.
  • Barclays first reported a position in Apollomics in Q3 2023 and held it in 1 quarter.
  • Barclays's Apollomics position peaked at $3.39K in Q3 2023.
  • 12 funds tracked by Wall St. Rank held Apollomics as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.